Jacqueline Cawthray
Jacqueline Cawthray
Saskatchewan Centre for Cyclotron Sciences
Verified email at mail.usask.ca
TitleCited byYear
Acyclic Chelate with Ideal Properties for 68Ga PET Imaging Agent Elaboration
E Boros, CL Ferreira, JF Cawthray, EW Price, BO Patrick, DW Wester, ...
Journal of the American Chemical Society 132 (44), 15726-15733, 2010
1092010
Identification and specificity studies of small-molecule ligands for SH3 protein domains
SR Inglis, C Stojkoski, KM Branson, JF Cawthray, D Fritz, E Wiadrowski, ...
Journal of medicinal chemistry 47 (22), 5405-5417, 2004
812004
Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms
PF Salas, C Herrmann, JF Cawthray, C Nimphius, A Kenkel, J Chen, ...
Journal of medicinal chemistry 56 (4), 1596-1613, 2013
592013
H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals
EW Price, JF Cawthray, GA Bailey, CL Ferreira, E Boros, MJ Adam, ...
Journal of the American Chemical Society 134 (20), 8670-8683, 2012
562012
Ion exchange in hydroxyapatite with lanthanides
JF Cawthray, AL Creagh, CA Haynes, C Orvig
Inorganic chemistry 54 (4), 1440-1445, 2015
462015
H4octapa-Trastuzumab: Versatile Acyclic Chelate System for 111In and 177Lu Imaging and Therapy
EW Price, BM Zeglis, JF Cawthray, CF Ramogida, N Ramos, JS Lewis, ...
Journal of the American Chemical Society 135 (34), 12707-12721, 2013
442013
Evaluation of the H2dedpa Scaffold and its cRGDyK Conjugates for Labeling with 64Cu
E Boros, JF Cawthray, CL Ferreira, BO Patrick, MJ Adam, C Orvig
Inorganic chemistry 51 (11), 6279-6284, 2012
382012
H2CHXdedpa and H4CHXoctapaChiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals
CF Ramogida, JF Cawthray, E Boros, CL Ferreira, BO Patrick, MJ Adam, ...
Inorganic chemistry 54 (4), 2017-2031, 2015
352015
In vitro studies of lanthanide complexes for the treatment of osteoporosis
Y Mawani, JF Cawthray, S Chang, K Sachs-Barrable, DM Weekes, ...
Dalton Transactions 42 (17), 5999-6011, 2013
322013
1, 1′-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarials
C Herrmann, PF Salas, JF Cawthray, C de Kock, BO Patrick, PJ Smith, ...
Organometallics 31 (16), 5736-5747, 2012
282012
Iron (III)-binding of the anticancer agents doxorubicin and vosaroxin
KD Mjos, JF Cawthray, G Jamieson, JA Fox, C Orvig
Dalton Transactions 44 (5), 2348-2358, 2015
252015
Modular syntheses of H 4 octapa and H 2 dedpa, and yttrium coordination chemistry relevant to 86 Y/90 Y radiopharmaceuticals
EW Price, JF Cawthray, MJ Adam, C Orvig
Dalton Transactions 43 (19), 7176-7190, 2014
242014
What a Difference a Carbon Makes: H4octapa vs H4C3octapa, Ligands for In-111 and Lu-177 Radiochemistry
EW Price, BM Zeglis, JF Cawthray, JS Lewis, MJ Adam, C Orvig
Inorganic chemistry 53 (19), 10412-10431, 2014
232014
In vivo study and thermodynamic investigation of two lanthanum complexes, La (dpp) 3 and La (XT), for the treatment of bone resorption disorders
JF Cawthray, DM Weekes, O Sivak, AL Creagh, F Ibrahim, M Iafrate, ...
Chemical science 6 (11), 6439-6447, 2015
162015
3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents
MA Telpoukhovskaia, C Rodríguez-Rodríguez, JF Cawthray, LE Scott, ...
Metallomics 6 (2), 249-262, 2014
162014
Dipicolinate complexes of gallium (III) and lanthanum (III)
DM Weekes, CF Ramogida, MG Jaraquemada-Pelaez, BO Patrick, C Apte, ...
Inorganic chemistry 55 (24), 12544-12558, 2016
142016
3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability
MA Telpoukhovskaia, JF Cawthray, C Rodriguez-Rodriguez, LE Scott, ...
Bioorganic & medicinal chemistry letters 25 (17), 3654-3657, 2015
142015
Bone-seeking agents for the treatment of bone disorders
J Cawthray, E Wasan, K Wasan
Drug delivery and translational research 7 (4), 466-481, 2017
82017
Gallium (III) and iron (III) complexes of quinolone antimicrobials
KD Mjos, JF Cawthray, E Polishchuk, MJ Abrams, C Orvig
Dalton Transactions 45 (33), 13146-13160, 2016
82016
La (III) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La (dpp) 3 and La (XT), and evaluation as treatments for bone resorption disorders
DM Weekes, JF Cawthray, M Rieder, J Syeda, M Ali, E Wasan, ...
Metallomics 9 (7), 902-909, 2017
52017
The system can't perform the operation now. Try again later.
Articles 1–20